𝔖 Bobbio Scriptorium

✦ LIBER ✦

REGENT trial: no added benefit with selected stem cells

Book ID: 120842150
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2008
Weight: 133 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200816550-00022

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

No benefit of treatment with cyclophosph

No benefit of treatment with cyclophosphamide and autologous blood stem cell transplantation in multifocal motor neuropathy

✍ H. W. Axelson; G. Öberg; H. Askmark 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

TCTAP A-154 Intracoronary Infusion of Bo

TCTAP A-154 Intracoronary Infusion of Bone Marrow-derived Selected CD34+CXCR4+ Cells and Non-selected Mononuclear Cells in Patients with Acute STEMI and Reduced Left Ventricular Ejection Fraction. Extended 6-year Follow-up of Randomized, Multicenter REGENT Trial

✍ Wojakowski, Wojciech 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Phase I trial of chloroquinoxaline sulfo

Phase I trial of chloroquinoxaline sulfonamide (CQS): A unique agent with activity in NSCLC selected for study based on activity in an in vitro stem cell assay

📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 134 KB

Concise Review: No Breakthroughs for Hum

Concise Review: No Breakthroughs for Human Mesenchymal and Embryonic Stem Cell Culture: Conditioned Medium, Feeder Layer, or Feeder-Free; Medium with Fetal Calf Serum, Human Serum, or Enriched Plasma; Serum-Free, Serum Replacement Nonconditioned Medium, or Ad Hoc Formula? All That Glitters Is Not Gold!

✍ Ferdinando Mannello; Gaetana A. Tonti 📂 Article 📅 2007 🏛 AlphaMed Press 🌐 English ⚖ 121 KB